Diaphorina citri psyllid: psy2647

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Zinc finger protein Gfi-1	Transcription repressor essential for hematopoiesis. Functions in a cell-context and development-specific manner. Binds to 5'-TAAATCAC[AT]GCA-3' in the promoter region of a large number of genes. Component of several complexes, including the EHMT2-GFI1-HDAC1, AJUBA-GFI1-HDAC1 and RCOR-GFI-KDM1A-HDAC complexes, that suppress, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Regulates neutrophil differentiation, promotes proliferation of lymphoid cells, and is required for granulocyte development. Mediates, together with U2AF1L4, the alternative splicing of CD45 and controls T-cell receptor signaling. Regulates the endotoxin-mediated Toll-like receptor (TLR) inflammatory response by antagonizing RELA. Cooperates with CBFA2T2 to regulate ITGB1-dependent neurite growth. Controls cell-cycle progression by repressing CDKNIA/p21 transcription in response to TGFB1 via recruitment of GFI1 by ZBTB17 to the CDKNIA/p21 promoter. Required for the maintenance of inner ear hair cells.	confident	Q99684
Zinc finger protein Gfi-1	Transcription repressor essential for hematopoiesis. Functions in a cell-context and development-specific manner. Binds to 5'-TAAATCAC[AT]GCA-3' in the promoter region of a large number of genes. Component of several complexes, including the EHMT2-GFI1-HDAC1, AJUBA-GFI1-HDAC1 and RCOR-GFI-KDM1A-HDAC complexes, that suppress, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Regulates neutrophil differentiation, promotes proliferation of lymphoid cells, and is required for granulocyte development. Mediates, together with U2AF1L4, the alternative splicing of CD45 and controls T-cell receptor signaling. Regulates the endotoxin-mediated Toll-like receptor (TLR) inflammatory response by antagonizing RELA. Cooperates with CBFA2T2 to regulate ITGB1-dependent neurite growth. Controls cell-cycle progression by repressing CDKNIA/p21 transcription in response to TGFB1 via recruitment of GFI1 by ZBTB17 to the CDKNIA/p21 promoter. Required for the maintenance of inner ear hair cells.	confident	P70338
Zinc finger protein Gfi-1	Transcription repressor essential for hematopoiesis. Functions in a cell-context and development-specific manner. Binds to 5'-TAAATCAC[AT]GCA-3' in the promoter region of a large number of genes. Component of several complexes, including the EHMT2-GFI1-HDAC1, AJUBA-GFI1-HDAC1 and RCOR-GFI-KDM1A-HDAC complexes, that suppress, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Regulates neutrophil differentiation, promotes proliferation of lymphoid cells, and is required for granulocyte development. Mediates, together with U2AF1L4, the alternative splicing of CD45 and controls T-cell receptor signaling. Regulates the endotoxin-mediated Toll-like receptor (TLR) inflammatory response by antagonizing RELA. Cooperates with CBFA2T2 to regulate ITGB1-dependent neurite growth. Controls cell-cycle progression by repressing CDKNIA/p21 transcription in response to TGFB1 via recruitment of GFI1 by ZBTB17 to the CDKNIA/p21 promoter. Required for the maintenance of inner ear hair cells.	confident	Q5DWN0

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0044212 [MF]	transcription regulatory region DNA binding	confident	GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0070105 [BP]	positive regulation of interleukin-6-mediated signaling pathway	confident	GO:0023051, GO:0010646, GO:0001959, GO:0008150, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0060759, GO:0001961, GO:0048518, GO:0060760, GO:0010647, GO:0070103, GO:0050789, GO:0048522
GO:0016604 [CC]	nuclear body	confident	GO:0044446, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0005575, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422
GO:0000122 [BP]	negative regulation of transcription from RNA polymerase II promoter	confident	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0010956 [BP]	negative regulation of calcidiol 1-monooxygenase activity	confident	GO:0060556, GO:0080090, GO:0019222, GO:0031326, GO:0060558, GO:0031323, GO:0046890, GO:0043086, GO:0051341, GO:0050789, GO:0065007, GO:0044092, GO:0065009, GO:0032769, GO:0019216, GO:0019218, GO:0032768, GO:0050790, GO:0009889, GO:0050794, GO:0050810, GO:0030656, GO:0051354, GO:0008150
GO:0016363 [CC]	nuclear matrix	confident	GO:0034399, GO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0034121 [BP]	regulation of toll-like receptor signaling pathway	confident	GO:0009966, GO:0048583, GO:0050794, GO:0008150, GO:0002682, GO:0023051, GO:0065007, GO:0010646, GO:0050789
GO:0017053 [CC]	transcriptional repressor complex	confident	GO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0005515 [MF]	protein binding	confident	GO:0003674, GO:0005488
GO:0010977 [BP]	negative regulation of neuron projection development	confident	GO:0010975, GO:0030154, GO:0051129, GO:0051128, GO:0031345, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0008150, GO:0051239, GO:0048731, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0051960, GO:2000026, GO:0007275, GO:0044763, GO:0048523
GO:0030854 [BP]	positive regulation of granulocyte differentiation	probable	GO:0002761, GO:1902107, GO:0002763, GO:0051094, GO:0050793, GO:0065007, GO:0045597, GO:0045595, GO:0050794, GO:0030852, GO:0050789, GO:1902105, GO:0045639, GO:0002682, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0045637, GO:0048522
GO:0000083 [BP]	regulation of transcription involved in G1/S phase of mitotic cell cycle	probable	GO:0080090, GO:0019222, GO:0031326, GO:0000082, GO:0044770, GO:0044772, GO:0022402, GO:0022403, GO:0050789, GO:0044699, GO:0051325, GO:0051329, GO:0019219, GO:0006357, GO:0065007, GO:0007049, GO:2000112, GO:0010468, GO:0000278, GO:0060255, GO:0031323, GO:0009987, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:2001141, GO:0051252, GO:0006355, GO:0010556, GO:0044763
GO:0030218 [BP]	erythrocyte differentiation	probable	GO:0030154, GO:0042592, GO:0007275, GO:0044699, GO:0048869, GO:0002262, GO:0008150, GO:0048513, GO:0065007, GO:0048534, GO:0065008, GO:0032502, GO:0034101, GO:0032501, GO:0009987, GO:0044767, GO:0044763, GO:0030097, GO:0002520, GO:0048872, GO:0044707, GO:0048856, GO:0002376, GO:0030099, GO:0048731
GO:0001085 [MF]	RNA polymerase II transcription factor binding	probable	GO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0032088 [BP]	negative regulation of NF-kappaB transcription factor activity	probable	GO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0050789, GO:2000112, GO:0060255, GO:0065007, GO:0044092, GO:0065009, GO:0010468, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:2001141, GO:0043433, GO:0051090, GO:0051252, GO:0006355, GO:0010556
GO:0042491 [BP]	auditory receptor cell differentiation	probable	GO:0044707, GO:0030154, GO:0032501, GO:0060113, GO:0008544, GO:0007275, GO:0044699, GO:0035315, GO:0048869, GO:0008150, GO:0048513, GO:0043583, GO:0030855, GO:0032502, GO:0009987, GO:0030182, GO:0060429, GO:0048699, GO:0009888, GO:0044767, GO:0044763, GO:0022008, GO:0048839, GO:0007399, GO:0007423, GO:0009913, GO:0048856, GO:0042490, GO:0048731
GO:0008270 [MF]	zinc ion binding	probable	GO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0007422 [BP]	peripheral nervous system development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0005730 [CC]	nucleolus	probable	GO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0005739 [CC]	mitochondrion	probable	GO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0060215 [BP]	primitive hemopoiesis	probable	GO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048568, GO:0048856, GO:0035162, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0071222 [BP]	cellular response to lipopolysaccharide	probable	GO:0070887, GO:0032496, GO:0044699, GO:0051716, GO:0033993, GO:0009617, GO:0071310, GO:0071219, GO:0071216, GO:0009987, GO:0071396, GO:0008150, GO:0042221, GO:0051707, GO:0010033, GO:0051704, GO:1901700, GO:1901701, GO:0009607, GO:0050896, GO:0002237, GO:0044763
GO:0042660 [BP]	positive regulation of cell fate specification	probable	GO:0051094, GO:0050793, GO:0010453, GO:0050794, GO:0045597, GO:0045595, GO:0042659, GO:0008150, GO:0048518, GO:0065007, GO:0050789, GO:0048522
GO:0001077 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	probable	GO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0005667 [CC]	transcription factor complex	probable	GO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0007638 [BP]	mechanosensory behavior	probable	GO:0009628, GO:0009605, GO:0044708, GO:0050896, GO:0007610, GO:0008150, GO:0009612
GO:0043425 [MF]	bHLH transcription factor binding	probable	GO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0009996 [BP]	negative regulation of cell fate specification	probable	GO:0051093, GO:0050793, GO:0010453, GO:0010454, GO:0050794, GO:0008150, GO:0045596, GO:0045595, GO:0065007, GO:0042659, GO:0048519, GO:0050789, GO:0048523
GO:0003705 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	probable	GO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0042472 [BP]	inner ear morphogenesis	probable	GO:0042471, GO:0048598, GO:0048839, GO:0048562, GO:0044707, GO:0007423, GO:0048568, GO:0032501, GO:0048856, GO:0009887, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0043583, GO:0048731, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0016032 [BP]	viral reproduction	probable	GO:0009987, GO:0044764, GO:0008150, GO:0051704
GO:0048813 [BP]	dendrite morphogenesis	probable	GO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0016358, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0048731, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048812, GO:0044763
GO:0000978 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding	probable	GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001159, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0000987, GO:0003674, GO:0097159, GO:1901363, GO:0005488
GO:0008283 [BP]	cell proliferation	probable	GO:0008150, GO:0044699
GO:0046929 [BP]	negative regulation of neurotransmitter secretion	probable	GO:0051046, GO:0051048, GO:0051049, GO:0050804, GO:0023051, GO:0051589, GO:0051588, GO:0010646, GO:0050789, GO:0060341, GO:0044057, GO:0065007, GO:0048519, GO:0051051, GO:0050794, GO:0046928, GO:0008150, GO:0051239, GO:0032879, GO:0031644, GO:0051969, GO:0048523
GO:0043066 [BP]	negative regulation of apoptotic process	probable	GO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0051572 [BP]	negative regulation of histone H3-K4 methylation	probable	GO:0033044, GO:0009892, GO:0031057, GO:0019222, GO:0033043, GO:0031324, GO:0031323, GO:0051129, GO:0051128, GO:0051569, GO:0031056, GO:0050789, GO:0044699, GO:0080090, GO:0051248, GO:0010605, GO:0051246, GO:0008150, GO:0065007, GO:0031399, GO:0048519, GO:0060255, GO:0009987, GO:0050794, GO:0031060, GO:0031061, GO:0032269, GO:0032268, GO:0031400, GO:0010639, GO:0044763, GO:0048523, GO:2001251
GO:0051574 [BP]	positive regulation of histone H3-K9 methylation	probable	GO:0033044, GO:0009893, GO:0019222, GO:0033043, GO:0031325, GO:0031323, GO:0051128, GO:0031056, GO:0031058, GO:0050789, GO:0080090, GO:0010604, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0051130, GO:0060255, GO:0050794, GO:0031060, GO:0031062, GO:0051570, GO:0032268, GO:0031401, GO:0010638, GO:0008150, GO:2001252, GO:0048522
GO:0010957 [BP]	negative regulation of vitamin D biosynthetic process	probable	GO:0060556, GO:0080090, GO:0019222, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0065007, GO:0046890, GO:0009892, GO:0046137, GO:0050789, GO:0009890, GO:0045833, GO:0010894, GO:0048519, GO:0051055, GO:0019216, GO:0045939, GO:0019218, GO:0009889, GO:0050794, GO:0050810, GO:0030656, GO:0008150, GO:0048523
GO:0006366 [BP]	transcription from RNA polymerase II promoter	probable	GO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0016360 [BP]	sensory organ precursor cell fate determination	probable	GO:0060582, GO:0032501, GO:0060581, GO:0009653, GO:0007275, GO:0044699, GO:0007389, GO:0010160, GO:0048869, GO:0001709, GO:0048513, GO:0048645, GO:0048646, GO:0032502, GO:0009887, GO:0030154, GO:0009987, GO:0044767, GO:0008052, GO:0008150, GO:0003002, GO:0048731, GO:0045165, GO:0048859, GO:0007423, GO:0044707, GO:0048856, GO:0044763
GO:0000114 [BP]	regulation of transcription involved in G1 phase of mitotic cell cycle	probable	GO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0000080, GO:0022402, GO:0022403, GO:0051329, GO:0050789, GO:0044699, GO:0051325, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0007049, GO:0010468, GO:0000278, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0051318, GO:0008150, GO:0051171, GO:2001141, GO:0051252, GO:0006355, GO:0010556, GO:0044763
GO:0045893 [BP]	positive regulation of transcription, DNA-dependent	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0009891, GO:2000112, GO:0019219, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0010556, GO:0048522
GO:0001078 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription	probable	GO:0001227, GO:0003700, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0014018 [BP]	neuroblast fate specification	probable	GO:0030154, GO:0007275, GO:0044699, GO:0014016, GO:0048863, GO:0048865, GO:0048866, GO:0048869, GO:0001708, GO:0032502, GO:0032501, GO:0009987, GO:0014017, GO:0008150, GO:0048731, GO:0022008, GO:0048699, GO:0045165, GO:0007399, GO:0044707, GO:0048856, GO:0044763
GO:0046676 [BP]	negative regulation of insulin secretion	probable	GO:0090087, GO:0051046, GO:0051048, GO:0051049, GO:0023051, GO:0010646, GO:0050789, GO:0060341, GO:0065007, GO:0048519, GO:0051051, GO:0050796, GO:0050794, GO:0090276, GO:0046883, GO:0008150, GO:0046888, GO:0032879, GO:0090278, GO:0002791, GO:0002792, GO:0048523
GO:0042051 [BP]	compound eye photoreceptor development	probable	GO:0048749, GO:0044707, GO:0030154, GO:0048468, GO:0009653, GO:0007275, GO:0044699, GO:0042462, GO:0042461, GO:0048869, GO:0048513, GO:0048666, GO:0009887, GO:0032501, GO:0030182, GO:0048592, GO:0009987, GO:0044767, GO:0001654, GO:0048731, GO:0001754, GO:0022008, GO:0001751, GO:0001745, GO:0048699, GO:0007399, GO:0007423, GO:0048856, GO:0044763, GO:0046530, GO:0008150, GO:0032502
GO:0045646 [BP]	regulation of erythrocyte differentiation	probable	GO:0050793, GO:0045637, GO:0008150, GO:0045595, GO:0065007, GO:2000026, GO:0051239, GO:0002682, GO:0032844, GO:0050789, GO:0050794
GO:0008407 [BP]	chaeta morphogenesis	probable	GO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0044699, GO:0048731, GO:0009653, GO:0007275, GO:0022416
GO:0043392 [BP]	negative regulation of DNA binding	probable	GO:0051098, GO:0051101, GO:0051100, GO:0065007, GO:0044092, GO:0008150, GO:0065009
GO:0007411 [BP]	axon guidance	probable	GO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0043058 [BP]	regulation of backward locomotion	probable	GO:0008150, GO:0040012, GO:0065007, GO:0050789
GO:0043059 [BP]	regulation of forward locomotion	probable	GO:0008150, GO:0040012, GO:0065007, GO:0050789
GO:0001106 [MF]	RNA polymerase II transcription corepressor activity	probable	GO:0001191, GO:0003714, GO:0003712, GO:0001104, GO:0001076, GO:0003674, GO:0000989, GO:0000988
GO:0005886 [CC]	plasma membrane	probable	GO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction